Aspira Women's Health Inc. (AWHL)
2025-06-30 | ||||
---|---|---|---|---|
Total revenue | 2,404 | |||
Cost Of Goods And Services Sold | 870 | |||
Total cost of revenue | 870 | |||
Gross profit | 1,534 | |||
Sales and marketing | 679 | |||
Research and development | 704 | |||
General and administrative | 1,961 | |||
Total operating expenses | 3,344 | |||
Loss from operations | -1,810 | |||
Other (expense) income, net | -219 | |||
Interest expense, net | -13 | |||
Change in fair value of warrant liabilities | 624 | |||
Loss upon issuance of convertible notes carried at fair value | - | |||
Change in fair value of convertible notes | - | |||
Total other (expense) income, net | -856 | |||
Net loss | -2,666 | |||
Basic weighted average common shares used to compute net loss per common share | 35,564,032 | |||
Diluted weighted average common shares used to compute net loss per common share | 35,564,032 | |||
Net loss per share - basic | -0.07 | |||
Net loss per share - diluted | -0.07 |